NCT06625775 2026-03-18Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsTheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Phase 1 Recruiting392 enrolled
NCT03333343 2026-01-16Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCNovartisPhase 1 Active not recruiting105 enrolled